Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
Cancer Science & TherapyMarch 07-08, 2019
Barcelona, Spain
32nd Euro Congress on
S C I E N T I F I C P R O G R A M
conferenceseries.com
SCIENTIFIC PROGRAMDAY 1
Thursday, 07th March
08:30-09:00 Registrations
09:00-09:30 Introduction
09:30-09:50 COFFEE BREAK
09:50-11:50 Meeting Hall 01
KEYNOTE LECTURES
MEETING HALL 01 MEETING HALL 02
11:50-13:10 Talks On: Cancer Science
Talks On: Cancer Therapy
Tumour progression Chemotherapy
Tumour immunology Molecular targeted therapies
Carcinogenesis & Mutagenesis Hormone replacement therapy
Organ defined cancers Stem cell therapy
13:10-13:15 GROUP PHOTO
13:15-14:00 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
14:00-16:00 Talks On: Cancer Diagnosis and Screening Talks On: Cancer Metabolomics
Screening test Metabolic pathways
Biopsy Tumour cell proliferation
Sigmoidoscopy Oncogenomics
Nuclear imaging Metabolomics as biomarker
Molecular diagnosis and diagnostics Cancer Genome Atlas(TCGA)
16:00-16:20 COFFEE BREAK
MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)
Young Researchers in Cancer Science and Therapy
Workshop
Visit: https://cancerscience.insightconferences.com/
SCIENTIFIC PROGRAMDAY 2
Friday, 08th March
09:00-10:30 Meeting Hall 01
KEYNOTE LECTURES
10:30-10:50 COFFEE BREAK
MEETING HALL 01 MEETING HALL 02
10:50-12:50 Talks On: Cancer Nanotechnology and Tumor Virology
Talks On: Cancer Pharmacology
Active tumor targeting Cancer drug targets
Nanoparticle packages Clinical trials and drug discovery
Laser ablation Anticancer therapeutics
Viral-associated Cancers Preclinical models for drug evaluation
Viral mimicry of genes Research and analytical methods
Viral therapy Cancer vaccines
12:50-13:35 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
13:35-15:55 Talks On: Cancer Therapeutics and NovelApproaches
Talks On: Cancer Case Reports
Cancer epigenetics Unexpected/Unusual conditions
Molecular profiling techniques Rare surgical condition of a cancer case
New biologics & vaccines Novel surgical procedure
Immuno-oncology biomarkers and companion Adverse effects
Novel biomarker discovery cancer therapy database
15:55-16:15 COFFEE BREAK
MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)
Poster Presentations Workshop
Awards & Closing Ceremony
Visit: https://cancerscience.insightconferences.com/
32nd Euro Congress on Cancer Science
& Therapy
MARCH 07-08, 2019 | BARCELONA, SPAIN
AGENDA
SPEA
KER S
LOTS
AVAI
LABL
E
Colin Paul Spears MD is a medical oncologist-hematologist with a background in alkylating agent kinetics in collaboration with the late Prof. George Olah (Nobelist 1994, Chemistry) at the University of Southern California, where he pioneered nucleophilic selectivity assays. Dr. Spears was chair of the Cancer Center at Mercy General Hospital in Sacramento, California for 10 years, in private practice, 2006-2016, and is Professor of Hematology at California Northstate University College of Medicine near Sacramento, California.
Georgia Zhuo Chen is currently Professor of Hematology and Medical Biology in Emory University. Dr. Chen has received several awards from the US National Institutes of Health (NIH) as a PI in the study of lung and head and neck cancers in the past years. She has generated more than 160 publications in peer-reviewed journals and serves as an editorial board member for 5 journals. Dr. Chen received the NIH Career Development Award in 1998 and an award as a Georgia Cancer Coalition Distinguished Cancer Scholar in 2006.
Jia Changku is working as a Professor at Department of Hepatobiliary Pancreatic Surgery, Hangzhou First People’s Hospital, Nanjing Medical University, China
SPEA
KER S
LOTS
AVAI
LABL
E
Douglas E Gladstone is an Associate Professor in the Department of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a Clinical Director of the Outpatient Bone Marrow Transplant Unit. In 2017, he led an educational program discussing how to lower donor specific antibodies to permissible levels for allogeneic bone marrow transplantation at the Annual American Society of Hematology conference
Jehad Zweiri, lecturer in Cancer studies at the University of Liverpool Medical School, born and grew up in Jordan and received his Bachelor’s degree from the University of Jordan in 1990. He obtained his master degree from London School of Hygiene and Tropical Medicine/University of London, and then obtained his PhD degree in 2000 from Kings College Medical School/University of London, in the field of Immune Gene Therapy of Cancer under the supervision of Professor Farzin Farzaneh. He then started his work as Postdoctoral Associate at the department of Immunology and Medicine at the University of Liverpool in 2002. In 2010 he was appointed as a lecturer in the university of Liverpool medical school and he is currently fellow of the British Higher Education Academy since 2012.
Associate Professor Vincent Murray has been an academic at the University of NSW since 1990. Murray obtained his BSc (Hons) from Glasgow University, U.K. and his PhD from the National Institute for Medical Research, London, U.K. He carried out post-doctoral research at Princeton University, U.S.A and the Cancer Institute, Melbourne, Australia. He has been an active researcher in the field of molecular biology and cancer and his lab has concentrated on investigating the interaction of anti-tumour drugs with DNA. He has focussed his research on several cancer chemotherapeutic agents including bleomycin, cisplatin and cisplatin analogues. Murray has published over 100 peer-reviewed papers.
SPEA
KER S
LOTS
AVAI
LABL
E
A Graduate of the University of St Andrew’s in Scotland and the University of Manchester Medical School UK. Professor O’Dwyer underwent postgraduate clinical training in the North West of England and undertook a Research Fellowship in Harvard University, Boston, USA. She continues to be involved in clinical research supervising research fellows for PhD and MD degrees by theses. She has over 100 publications and has delivered over ninety invited lectures. She is actively involved with the Association of Coloproctology of Great Britain and Ireland (ACPGBI) being chair of the peritoneal malignancy committee, member of the multidisciplinary clinical committee, a former council member and North West Regional Representative.
Jaime Tisnado graduated from Leoncio Prado Military Academy. He received his BM degree from San Marcos National University, College of Sciences. He received his MD degree summa cum laude from the same San Marcos National University Medical School.. He then became an Assistant Professor of Radiology and Director of Interventional Radiology at Albany Medical College, Albany, NY, 1974-77. Thereafter he moved to Virginia Commonwealth University, in Richmond, VA, where he became Associate Professor of Radiology and Director of Interventional Radiology and eventually became Professor of Radiology and Professor of Surgery, at the same university from 1985 till 2010. Thereafter, he was named one of the few Professor Emeritus of Radiology and Surgery, all at the same Virginia Common wealth University in 2010 till now.
Professor Yingbin Liu,, serves as the director of Department of General Surgery, Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine. and the director of the Shanghai Research Institute of Biliary Tract Disease. In 2016, he was awarded the International Fellow of the American College of Surgeons. Professor Liu has been engaged in both clinical and basic research in the field of the hepatobiliary and pancreatic cancer since 1984. He has completed 7 projects of National Natural Science Foundation of China and more than 10 projects at provincial level or above.He has supervised more than 30 postgraduate and Ph.D. students and post-doctoral scholars in research field of stomach, liver and gallbladder cancers.
SPEA
KER S
LOTS
AVAI
LABL
E
Dr. Ashok Srivastava is Chief Executive Officer and Chief Medical Officer of Cure Pharmaceuticals, and ClinFomatrix Oncology, He has more than 15 years of experience in drug development, medical affairs and commercialization of cancer drugs including radiopharmaceutical and supportive care; Phase I – 4, and marketing commercialization of Hematology, Oncology and radio pharmaceutical drugs in USA, EU and Japan. He is leader in Cancer Drug Development Worldwide large and complex Phase 3 Clinical Trials in many countries. He contributed to 21-INDs and 7-NDAs of Cancer Drugs, acquisition /merger of company and drug for more than $700 million.
Dr. Bhattacharjee did her B.Sc in Biotechnology from Bangalore University in 2006 and M.Sc in Applied Genetics from Bangalore University in 2008. She then moved to England to pursue her DPhil (Phd) in Biochemistry from Oxford University where she studied the role of Fml1 and its partner proteins Mhf1 and Mhf2 in promoting genome stability. She was awarded her DPhil in 2012. During her time at Oxford, she was also a tutor at Greene’s College, Oxford. In 2013, Dr. Bhattacharjee moved to Cold Spring Harbor Laboratory, New York. At CSHL, her work has focused on understanding the epigenetic regulation of DNA repair. She is also an academic tutor at the Watson School of Biological studies, the school for graduate studies at CSHL.
Farnaz is currently studying Medical physics in PhD degree at RMIT University. She is a Clinical medical physicist with three years of experience in radiation oncology gained in both solo and group settings. Competent to independently perform treatment planning and treatment delivery duties. Good understanding of quality assurance for linear accelerators. To practice all aspects of clinical medical physics for an accurate, safe and effective delivery of radiotherapy treatment for the cancer patients, pursuing a broad range of clinical research projects in radiotherapy. Also now she is working at university as a course coordinator and also has a teaching experience in university in subjects such as radiotherapy, Physics of MRI and CT scan.
SPEA
KER S
LOTS
AVAI
LABL
E
Graduated in Pharmaceutical Sciences from the Faculty of Imperatriz - FACIMP / Wyden (2014). She was a Fellow of CNPQ / FAPEMA and a student of scientific initiation in the pharmacognosy, microbiology and chemistry laboratories of the FACIMP / Wyden Department of Pharmaceutical Sciences. He has experience in the areas of pharmacognosy, pharmacology, pharmacobotany and microbiology, working mainly on the following topics: Identification of secondary metabolites, organography and microtechnology, production of plant extracts and analysis of antimicrobial activity, such analyzes performed with leaves and oil-resin of Copaíba (Copaifera spp.). She currently holds a master's degree in Nanoscience and Nanobiotechnology at the University of Brasília (UnB) under the guidance of Prof. Dr. João Paulo Figueiró Longo, focused on the study of vascular remodeling in breast tumors and its influence on the Enhanced Permeability and Retention (EPR) effect with the application of a mathematical model to predict hemodynamic parameters
Lorenzo Belluomini, is working as a Medical Doctor at Department of Medical Oncology, University Hospital Ferrara, Italy
Professor Yingbin Liu,, serves as the director of Department of General Surgery, Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine. and the director of the Shanghai Research Institute of Biliary Tract Disease. In 2016, he was awarded the International Fellow of the American College of Surgeons. Professor Liu has been engaged in both clinical and basic research in the field of the hepatobiliary and pancreatic cancer since 1984. He has completed 7 projects of National Natural Science Foundation of China and more than 10 projects at provincial level or above.He has supervised more than 30 postgraduate and Ph.D. students and post-doctoral scholars in research field of stomach, liver and gallbladder cancers.
SPEA
KER S
LOTS
AVAI
LABL
E
Angie Bedoya is a dentist, MSc in biochemistry, she is a Ph.D. student in biotechnology at National University of Colombia. This work belongs to her thesis topic.
Sara is currently a medical student at King Saud University, vice president of student council and co-founder of nanotechnology club at her university. Her research interests are focused on the translational research of oncology, personalized medicine, artificial intelligence, and nanotechnology.
Dr Neeraj Jain is Associate Prof Radiation Oncology At Sri Guru Ram Das University Of Health Sciences Amritsar. He is eminent Radiation Oncologist and participated in Numerous national and international conferences and presented papers. He is Vice Chairman of Indian College Of Radiation Oncologists (ICRO). ICRO is an academic wing of AROI i.e. Association Of Radiation Oncologists of India. He is well versed in modern Radiotherapy techniques.
SPEA
KER S
LOTS
AVAI
LABL
E
Lina Elsalem earned her Ph.D. in Cancer Pharmacology from The Institute of CancerTherapeutics at University of Bradford, UK. She is a young researcher and investigator in the field of Cancer Research. Currently, she is working on projects related to drug metabolizing enzymes in colorectal and bladder carcinoma as well as bacterial drug resistance in wound infections. She presented more than 10 abstracts at prestigious national and international conferences. Currently, she is an assistant professor in the department of pharmacology at faculty of Medicine/ Jordan University of Science and Technology. Her research interests are focused in the role of hypoxia in the regulation of drug metabolizing enzymes in tumour microenvironment as well as drug resistance in solid tumours and bacterial infections.
Dr. Sina Ghanean earned his Ph.D. in Oral and maxillofacial surgery at Shahid Sadoughi University of Medical Sciences, Yazd, Iran. He has published more than 7 papers in reputed journals and presented more than 8 abstracts at prestigious national and international conferences. Also, he has participated in writing/editing 5 books/chapters in the field of oral and maxillofacial surgery. Currently, his research interests are focused in discovering new methods for early diagnosis and treatment of squamous cell carcinoma.
Ibrahim Elsayed Mohammed has completed his master degree in pharmacology at the age 0f 29 years from meical research institute, Alexandria university, Egypt, and now he is finishing his phD in pharmacology from Cairo university, Egypt. He is an assistant lecturer of pharmacology and toxicology at pharos university in Alexandria. He has published 4 papers in reputed journals(research journal of oncology , LIFE SCIENCES, journal of medical oncology, and journal of medical research institute.
SPEA
KER S
LOTS
AVAI
LABL
E
Magda Mohamed Sultan has completed her MD in clinical pathology and laboratory oncology from National Cancer Institute Cairo University.(1992) She was the Head of the hematology department of Medical Researh Institute .Alexandria University .Egypt for 8 Years (2007-2015) . She is now an emeritus professor in the institue , sharing in teaching for doctor and master degrees and she is the head of hematology department of Alborg LaB in alexandria since 1996 till now . She has published more than 25 papers and she is arbitrator for many thesis and many published papers.
Ahmed Malki is working as an associate professor of Biomedical Sciences College of Health Sciences Qatar University
M. A. Alnafea worked, taught, and trained in many local and international hospitals as a medical imaging technologist and a medical physicist. He has completed his PhD at the age of 33 years from the university of Surry, UK and postdoctoral studies from King Saud University. He then worked as Assistance Professor then as director of Radiologic Sciences Dept. for 2 years, He then worked for two years as Vice dean for Academic affair in the College of Applied Medical Sciences. He then worked as consultant at the ministry of higher education, vice ministry for scholarship, medical education department (2011-2015). Sense June 2015 he has being working as an academic and researcher. His Current research projects supported by the National Science, Technology and Innovation Plan (NSTIP) and King Abdulaziz City for Science and Technology. He is the Principal Investigator and Project Manager and the title of the current project:” Development of a proof-of-concept demonstration system for 3D coded aperture Scintimammography”.
Alvaro Macieira-Coelho French National Institute of Health (INSERM), France
Liane Deligdisch Icahn School of Medicine at Mount Sinai, USA
Tatiana Massarrah Gregorio Maranon Hospital, Spain
Sherry A Bradford AccuTheranostics, Inc., USA
Aleksandar Stefanovic Clinical Center of Serbia, Serbia
Nyla A Heerema The Ohio State University Wexner Medical Center, USA
Charles L Hitchcock The Ohio State University, USA
Alice Dragomir McGill University, Canada
M Helena Vasconcelos University of Porto, Portugal
Rita Lakhani Krishna University of Health Sciences, India
Audrey Claing Montreal University, Canada
Hirendra Nath Banerjee University of North Carolina, USA
Katarina Jeremic University of Belgrade, Serbia
Vasco Fonseca Centro Hospitalar Lisboa Ocidental, Portugal
Isaura Meza CINVESTAV, Mexico
Robert Thomas Bedford and Addenbrooke’s Cambridge University Hospitals, UK
Shanmugasundaram Ganapathy Kanniappan Johns Hopkins University, USA
Qi-Fei Wang The First Affiliated Hospital of Dalian Medical University, China
Kuniaki Arai Kanazawa University Hospital, Japan
Adnan Yousif Rojeab London College UCK, UK
Wioletta Rozpędek Medical University of Lodz, Poland
M Inês Silva University of Porto, Portuga
Diana Sousa University of Porto, Portugal
Joana Pereira University of Porto, Portugal
PAST AFFILIATESPA
ST A
FFIL
IATE
S
Visit: https://cancerscience.insightconferences.com/
Liyun Shi Hangzhou Normal University School of Medicine, China
Gina Marcela Méndez-Callejas University of Applied and Environmental Sciences, Colombia
Maria Isabel da G. S. Ramos University of Cape Verde, Africa
Adnan Yousif Rojeab London College UCK, UK
Robert Thomas Bedford and Addenbrooke’s Cambridge University Hospitals, UK
Sonia A Melo University of Porto, Portugal
Zofia Felicja Bielecka Warsaw Medical University, Poland
Mahmood Faraz Umea University, Sweden
Carolina F Ruivo Institute for Research and Innovation in Health, Portugal
Nuno Bastos University of Porto, Portugal
So Young Kim Chungbuk National University, South Korea
Sung S Choi Chung-Ang University College of Medicine, South Korea
Leclerc Anne-France University Hospital Centre of Liege, Belgium
Mahmood Faraz Umea University, Sweden
Madiha Nazir Uppsala University, Sweden
Fouad Azizi Hamad Medical Corporation, Qatar
Andrés Julián Gutiérrez-Escobar University of Applied and Environmental Sciences, Colombia
Purusottam Mohapatra Lund University, Sweden
Messafeur Abdelkrim University Sidi Bel Abbes, Algeria
Sanjay Gandhi Southmead Hospital, UK
PAST AFFILIATESPA
ST A
FFIL
IATE
S
Visit: https://cancerscience.insightconferences.com/
Vikas Leelavati Balasaheb Jadhav Dr.D.Y.Patil University, India
Abdulrahman A. S. Alsayyari Qassim University, Saudi Arabia
Masoud Hashemi Shahid Beheshti University of Medical Sciences, Iran
Hissa Mohammed National center for Cancer Care and Research, Qatar
Chih-Jen Hung Taichung Veterans General Hospital, Taiwan
M. A. Alnafea King Saud University, Saudi Arabia
Monica Kansal Jaypee Hospital, India
David Sipos University of Pecs Faculty of Health Sciences, Hungary
Amjed Eljaili Ysbyty Gwynedd, UK
Shahriari Mozhgan Tehran University, Iran
Daniel L. Farkas University of Southern California, USA
Claudia Paola Rivera-Uribe Nuevo León Autonomous University, Mexico
Ala khasawneh University of Pécs, Hungary
Syed Muhammad Anwar University of Engineering and Technology, Pakistan
Kunwarpal singh Sri Guru Ram Das Institute of Medical Sciences and Research, India
Shajeem Shahudeen Vivid Diagnostic Centre, India
Dongyeon Lee Yonsei University, South Korea
M. A. Alnafea King Saud University, Saudi Arabia
David Sipos University of Pecs Faculty of Health Sciences, Hungary
Ala khasawneh University of Pécs, Hungary
Mustafa Sabil United Kingdom
PAST AFFILIATESPA
ST A
FFIL
IATE
S
Visit: https://cancerscience.insightconferences.com/
Zang-Hee Cho Seoul National University, South Korea
Bin Zheng University of Oklahoma, USA
Michael L Goris Stanford University School of Medicine, USA
Bital Savir-Baruch Loyola University Medical Center, USA
Ilona Kowalik-Urbaniak Client Outlook Inc., Canada
Monika Beresova University of Debrecen, Hungary
Hang Joon Jo Mayo Clinic, USA
Elaine Iuanow Cleveland Clinic Foundation, USA
Barath Narayanan Narayanan University of Dayton, USA
Jamal Zweit Virginia Commonwealth University, USA
David A Gutman Emory University School of Medicine, USA
Limin Yang University of Iowa, USA
Tamara Feygin University of Pennsylvania, USA
Hesham El Sheikh Benha University, Egypt
Manohar Roda University of Mississippi, USA
Daniel Pastore Sao Paulo University School of Medicine, Brazil
Mafalda Gomes University of Porto, Portugal
Nilda Espinola-Zavaleta National Institute of Cardiology Ignacio Chavez, Mexico
Svjetlana Jefic University Clinical Centre of Repablic of Srpska, Bosnia and Herzegovina
Aminur Rahman National Institute of Neurosciences and Hospital, Bangladesh
Shivaram Poigai Arunachalam Mayo Clinic, USA
PAST AFFILIATESPA
ST A
FFIL
IATE
S
Visit: https://cancerscience.insightconferences.com/
Glimpses of Cancer Conferences
Barcelona Attractions
Cam
p Nou
Sta
dium
Tibidabo
Barrio
Got
ico
Park
Gue
ll
Pica
sso
Mus
eum
Las S
agra
da Fam
ilia
Mon
tjuïc
Castl
e
Cass
a Bat
llo
La B
arce
lone
ta